tirzepatide and prediabetes in Patients with Obesity During a 3-year study, most patients reverted to normoglycemia. https://jwat.ch/4eFTJD8 Tirzepatide: A Promising Drug for
Description
The relative decrease in fat mass vs
To stay informed about any developments, it is advisable to follow reliable sources, like FDA Drug Safety Information
Tirzepatide has no equivalent outcomes trial yet
It looks like progress
Its mechanism primarily targets estrogen production reduction, further stimulating the release of follicle-stimulating hormone
Two points are worth being clear about
